Risky business

The Science may make sense, but plans for new nuclear plant capacity could yet be thwarted by difficult economics. Investor caution remains the order of the day, as prohibitive capital-investment costs and hefty decommissioning expenses run into tens of billions of dollars, James Gavin writes.